Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

Biological Diversity: Draft Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization to the Convention on Biological Diversity

Oct 14 2010
The Heads of Biotechnology Associations: Asia, Europe and the Americas and their members support the agreed objective of the Protocol and the greater goal to establish a practical and workable international regime governing access to genetic resources and the fair and equitable sharing of benefits arising from these resources.

Low Level Presence

Oct 14 2010
District Court Ruling Exposes Biotechnology to Unprecedented Tort Liability. BIO disputes the District Court Ruling that exposes biotechnology companies to unprecedented tort liability for the development and sale of biotechnology products that are physically harmless and not subject to regulatory remediation or penalty.

Letter to Ms. Cindy Smith, USDA APHIS Regarding BRS Notification Planting Reports

Oct 6 2010
In September 2010, USDA’s Biotechnology Regulatory Services (BRS) began implementing the latest revisions to its User’s Guide for Notification, in spite of a request from BIO for a delay until a system for providing accurate and timely planting reports can be developed. In this letter, BIO proposes a compromise on behalf of our member companies.

Stewardship: Actions to be Taken Prior to Launching Special Traits

Oct 4 2010
BIO policy recommends that BIO members anticipate, consider and develop approaches to help manage and mitigate any potential significant, unintentional processing, product functional or compositional negative effects in crop use or processing streams.

USTR’s Annual Report on Sanitary and Phytosanitary (SPS)

Oct 4 2010
BIO encourages USTR and other U.S. government agencies to renew efforts to ensure that any SPS measures affecting exports of U.S. products derived from modern biotechnology be based on scientifically verifiable criteria and be consistent with the SPS Agreement.

Stewardship: Actions to be Taken Prior to Launching Special Traits

Oct 4 2010
BIO policy recommends that BIO members anticipate, consider and develop approaches to help manage and mitigate any potential significant, unintentional processing, product functional or compositional negative effects in crop use or processing streams.

Synthetic Biology: Proposals for Regulating Industry Uses of New Biotechnologies

Oct 1 2010
BIO submitted letters to the White House Office of Science and Technology Policy and the Presidential Commission for the Study of Bioethical Issues proposing formation of a federal interagency working group to coordinate all agencies’ approaches to regulating synthetic biology.

Pandemic Influenza: Vaccine production and additional planning for future possible pandemic influenza

Oct 1 2010
BIO recommends that countries and NGO’s be encouraged to allocate funds to broad educational programs directed to the public on the importance of both individual and community protection against seasonal influenza as a way to build stronger understanding of the role of vaccines in preventing influenza now and in the future.

IRS: Implementation of Biopharmaceuticals Manufacturers Fee

Sep 30 2010
BIO is hopeful that the IRS, Treasury and the specified government agencies will work closely with industry to ensure that the fee is implemented in as fair and transparent a manner as possible.

Intellectual Property: Compulsory Licenses Published by the Department of Industrial Policy and Promotion within India's Ministry of Commerce and Industry

Sep 29 2010
BIO is disappointed to see the recent DIPP’s discussion paper on compulsory licensing of biopharmaceuticals, which sends a deeply troubling message to investors and collaborators at a time when the industry and the Government of India are seeking to increase investment, collaboration, and innovation in the biotech sector.